Comparative Tolerability of Therapies for Cytomegalovirus Retinitis

ISSN： 0114-5916

Source： Drug Safety, Vol.21, Iss.3, 1999-09, pp. : 203-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Tolerability of Therapies for Ulcerative Colitis

By Ardizzone S. Porro G.B.

Drug Safety, Vol. 25, Iss. 8, 2002-01 ,pp. : 561-582

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy

By Zojer N. Keck A.V. Pecherstorfer M.

Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. : 389-406

Adis International

Access to resources Recommend Favorite

Therapeutic developments in cytomegalovirus retinitis

By Hoffman V.F. Skiest D.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 207-220

Informa Healthcare

Access to resources Recommend Favorite

Alemtuzumab: Cytomegalovirus retinitis: case report

Reactions Weekly, Vol. 1, Iss. 1253, 2009-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Therapies for human cytomegalovirus

By Rios S L Baracho V G Oliveira KB A Rizzo Prof. Luiz Vicente

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 4, 2007-04 ,pp. : 407-418

Informa Healthcare

Access to resources Recommend Favorite